5-androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression

International Immunopharmacology

Volumn 7, Issue 4, 2007, Pages 500-505

  Stickney, Dwight R ^a   Dowding, Charles ^a   Authier, Simon ^b   Garsd, Armando ^a   Onizuka Handa, Nanette ^a   Reading, Christopher ^a   Frincke, James M ^a  

^a Hollis Eden Pharmaceuticals Inc   (United States)

^b NONE   (Canada)

Author keywords

Acute radiation syndrome; AED; Androstenediol; Hematopoiesis; Radiation protection; Rhesus macaques

Indexed keywords

ANDROSTENEDIOL; ANTIBIOTIC AGENT;

ACCURACY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; CONTROLLED STUDY; FEMALE; MALE; MORTALITY; NEUTROPENIA; NONHUMAN; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; RHESUS MONKEY; STEROID ANALYSIS; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

ANDROSTENEDIOL; ANIMALS; FEMALE; GAMMA RAYS; MACACA MULATTA; MALE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; THROMBOCYTOPENIA; X-RAYS;

EID: 33847073425     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.12.005     Document Type: Article

References (34)

1. Turai I., Veress K., Gunalp B., and Souchkevitch G. Medical response to radiation incidents and radionuclear threats. BMJ 328 (2004) 568-572
2. Holdstock D., and Waterston L. Nuclear weapons, a continuing threat to health. Lancet 355 (2000) 1544-1547
3. Dainiak N., Waselenko J.K., Armitage J.O., MacVittie T.J., and Farese A.M. The hematologist and radiation casualties. Hematology (Am Soc Hematol Educ Program) (2003) 473-496
4. Waselenko J.K., MacVittie T.J., Blakely W.F., Pesik N., Wiley A.L., Dickerson W.E., et al. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 140 (2004) 1037-1051
5. Code of Federal Regulations title 21 food and drugs. Part 314 - subpart I - approval of new drugs when human efficacy studies are not ethical or feasible. Code of Federal Regulations (2005), U.S. Govt. Print. Off., Washington 166-169
6. Whitnall M.H., Elliott T.B., Harding R.A., Inal C.E., Landauer M.R., Wilhelmsen C.L., et al. Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int J Immunopharmacol 22 (2000) 1-14
7. Whitnall M.H., Inal C.E., Jackson III W.E., Miner V.L., Villa V., and Seed T.M. In vivo radioprotection by 5-androstenediol: stimulation of the innate immune system. Radiat Res 156 (2001) 283-293
8. Whitnall M.H., Elliott T.B., Landauer M.R., Jackson III W.E., Wilhelmsen C.L., McKinney L., et al. In vivo protection against gamma-irradiation with 5-androstenediol. Exp Biol Med (Maywood) 226 (2001) 625-627
9. Whitnall M.H., Elliott T.B., Landauer M.R., Wilhelmsen C.L., McKinney L., Kumar K.S., et al. Protection against gamma-irradiation with 5-androstenediol. Mil Med 167 (2002) 64-65
10. Whitnall M.H., Wilhelmsen C.L., McKinney L., Miner V., Seed T.M., and Jackson III W.E. Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice. Immunopharmacol Immunotoxicol 24 (2002) 595-626
11. Stickney D.R., Dowding C., Garsd A., Ahlem C., Whitnall M., McKeon M., et al. 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression. Int Immunopharmacol 6 (2006) 1706-1713
12. National Research Council (U.S.) Institute of Laboratory Animal Resources. Guide for the care and use of laboratory animals. 7th ed (1996.), National Academy Press, Washington, D. C.
13. Code of Federal Regulations title 21 food and drugs. Part 58 good laboratory practice for nonclinical laboratory studies. Code of Federal Regulations (2005), U.S. Govt. Print. Off., Washington, D. C. 300-314
14. Jackson III WE. Literature estimates and calibration studies of the total body irradiation dose to achieve 50% mortality in primates. Unpublished data from James R. Eltringham, MD via Thomas J. MacVittie, MD. (Data on file). In: Garsd A, Stickney DR, editors. Bethesda, MD; 2004.
15. Almond P.R., Biggs P.J., Coursey B.M., Hanson W.F., Huq M.S., Nath R., et al. AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams. Med Phys 26 (1999) 1847-1870
16. StatXact 7 PROCs: Statistical software for exact nonparametric inferences, users manual. 7th ed. 7th ed (2005), Cytel Inc., Cambridge, MA
17. SAS/STAT user's guide: version 8 (1999), SAS Institute Inc., Cary, NC
18. Agresti A. Small-sample conditional inference for linear logit model. Categorical data analysis. 2nd ed. New York: John Wiley & Sons, Inc., 2002. pp 151-153; 181; 253.
19. Gootenberg J.E., and NEULASTA™ (Pegfilgrastim). BLA no. 125031, approval history. Medical officer clinical review of BLA STN 125031. Part 1 of 3 (2002), FDA, Office of Oncology Drug Products, Silver Springs, MD 1-42
20. In a conversation with D.D. Leavitt, Ph.D. (July 2006). Isodose measurements and beam characteristics of cobalt-60 photons and 6 MV X-rays with 1 cm beam modifier externally superimposed.
21. McBride W.H., Chiang C.S., Olson J.L., Wang C.C., Hong J.H., Pajonk F., et al. A sense of danger from radiation. Radiat Res 162 (2004) 1-19
22. Wright E.G. Radiation-induced genomic instability in haemopoietic cells. Int J Radiat Biol 74 (1998) 681-687
23. Lorimore S.A., and Wright E.G. Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol 79 (2003) 15-25
24. Kaya-Aerts F.S.F., Visser T.P., Reading C.L., Frincke J.M., Verstegen M.M.A., Stickney D.R., et al. HE2100 (5-androstene-3 beta, 17 beta-diol) after cytoreductive total body irradiation of rhesus monkeys promotes the recovery of immature CD34+ bone marrow cells; accelerates platelet, granulocyte and red cell reconstitution, and alleviates neutropenia and anemia. Blood 106 (2005) 131b [Abstract #4203]
25. Bodey G.P., Buckley M., Sathe Y.S., and Freireich E.J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64 (1966) 328-340
26. Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325 (1991) 164-170
27. Klinger M.H., and Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22 (2002) 913-922
28. Weksler B.B., and Nachman R.L. Rabbit platelet bactericidal protein. J Exp Med 134 (1971) 1114-1130
29. Yeaman M.R., Puentes S.M., Norman D.C., and Bayer A.S. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun 60 (1992) 1202-1209
30. Clawson C.C., and White J.G. Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol 65 (1971) 381-397
31. Hirsch J.G. Comparative bactericidal activities of blood serum and plasma serum. J Exp Med 112 (1960) 15-22
32. Copley A.L., and Witte S. On physiological microthromboembolization as the primary platelet function: elimination of invaded particles from the circulation and its pathogenic significance. Thromb Res 8 (1976) 251-262
33. Koo S.P., Yeaman M.R., and Bayer A.S. Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase. Infect Immun 64 (1996) 3758-3764
34. Yeaman M.R., and Bayer A.S. Antimicrobial peptides from platelets. Drug Resist Updat 2 (1999) 116-126